Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2009

Open Access 01-12-2009 | Research

The impact of itch symptoms in psoriasis: results from physician interviews and patient focus groups

Authors: Denise Globe, Martha S Bayliss, David J Harrison

Published in: Health and Quality of Life Outcomes | Issue 1/2009

Login to get access

Abstract

Background

The objective of this qualitative study was to better understand the impact of psoriasis symptoms using a 3-part process: 1) develop a disease model for psoriasis to identify the most important concepts relevant to psoriasis patients; 2) conduct interviews with dermatologists to identify key areas of clinical concern; and 3) explore psoriasis patients' perceptions of the impact of psoriasis.

Methods

A disease model was developed from a review of the published literature and later revised based on the findings of clinician interviews and patient focus groups. To confirm the clinical relevance of the concepts identified in the disease model, 5 dermatologists were selected and interviewed one-on-one. They were asked to rate major psoriasis symptoms according to importance and bothersomeness level to patients on separate scales of 1 to 10. Results of clinician interviews were used to develop interview guides for patient focus groups. To identify important domains of psoriasis, 39 patients participated in 5 separate concept elicitation focus groups. Four focus groups included patients with severe psoriasis (n = 31) and one included patients with mild psoriasis (n = 8). Patients were asked to describe their current psoriasis symptoms and to rate them on a scale of 1 to 10, according to importance, severity, and troublesomeness. An average mean rating was calculated for each symptom throughout all focus groups.

Results

Clinicians most frequently mentioned itch (n = 5), psoriatic arthritis or "joint pains" (n = 4), flaking (n = 4), and pain (n = 3) as primary physical symptoms of psoriasis. Three clinicians gave a rating of 10 for the importance of itch; two clinicians gave ratings of 8 and 7 for importance. The majority of patients rated itch as the most important (31/39), most severe (31/39), and most troublesome (24/39) symptom and noted that itch negatively impacted daily activities (eg, concentration, sleep, ability to attend work or school), as well as emotions (eg, anxiety and embarrassment).

Conclusion

These analyses suggest that itch is one of the most important symptoms of psoriasis, contributing to diminished health-related quality of life (HRQoL) in patients with both mild and severe disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T: Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004,9(2):136–139.CrossRef Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T: Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004,9(2):136–139.CrossRef
2.
go back to reference de Korte J, Sprangers MA, Mombers FM, Bos JD: Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc 2004,9(2):140–147.CrossRef de Korte J, Sprangers MA, Mombers FM, Bos JD: Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc 2004,9(2):140–147.CrossRef
3.
go back to reference Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM: Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999,41(3 Pt 1):401–407.CrossRef Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM: Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999,41(3 Pt 1):401–407.CrossRef
4.
go back to reference Gaspari AA: Innate and adaptive immunity and the pathophysiology of psoriasis. J Am Acad Dermatol 2006,54(3 Suppl 2):S67–80.CrossRef Gaspari AA: Innate and adaptive immunity and the pathophysiology of psoriasis. J Am Acad Dermatol 2006,54(3 Suppl 2):S67–80.CrossRef
5.
go back to reference Tschachler E: Psoriasis: the epidermal component. Clin Dermatol 2007,25(6):589–595.CrossRef Tschachler E: Psoriasis: the epidermal component. Clin Dermatol 2007,25(6):589–595.CrossRef
6.
go back to reference Dika E, Bardazzi F, Balestri R, Maibach HI: Environmental factors and psoriasis. Curr Probl Dermatol 2007, 35: 118–135.CrossRef Dika E, Bardazzi F, Balestri R, Maibach HI: Environmental factors and psoriasis. Curr Probl Dermatol 2007, 35: 118–135.CrossRef
7.
go back to reference Finlay AY, Khan GK: Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol 1994,19(3):210–216.CrossRef Finlay AY, Khan GK: Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol 1994,19(3):210–216.CrossRef
8.
go back to reference Shikiar R, Willian MK, Okun MM, Thompson CS, Revicki DA: The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study. Health Qual Life Outcomes 2006, 4: 71.CrossRef Shikiar R, Willian MK, Okun MM, Thompson CS, Revicki DA: The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study. Health Qual Life Outcomes 2006, 4: 71.CrossRef
9.
go back to reference Finlay AY: Quality of life assessments in dermatology. Semin Cutan Med Surg 1998,17(4):291–296.CrossRef Finlay AY: Quality of life assessments in dermatology. Semin Cutan Med Surg 1998,17(4):291–296.CrossRef
10.
go back to reference Patrick DL, Burke LB, Powers JH, Scott JA, Rock EP, Dawisha S, O'Neill R, Kennedy DL: Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health 2007,10(Suppl 2):S125–137.CrossRef Patrick DL, Burke LB, Powers JH, Scott JA, Rock EP, Dawisha S, O'Neill R, Kennedy DL: Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health 2007,10(Suppl 2):S125–137.CrossRef
11.
go back to reference Mays N, Pope C: Rigour and qualitative research. BMJ 1995,311(6997):109–112.CrossRef Mays N, Pope C: Rigour and qualitative research. BMJ 1995,311(6997):109–112.CrossRef
12.
go back to reference Rowan M, Huston P: Qualitative research articles: information for authors and peer reviewers. CMAJ 1997,157(10):1442–1446. Rowan M, Huston P: Qualitative research articles: information for authors and peer reviewers. CMAJ 1997,157(10):1442–1446.
13.
go back to reference Bowen GA: Naturalistic inquiry and the saturation concept: a research note. Qualitative Research 2008,8(1):137–152.CrossRef Bowen GA: Naturalistic inquiry and the saturation concept: a research note. Qualitative Research 2008,8(1):137–152.CrossRef
14.
go back to reference Guest G, Bunce A, Johnson L: How many interviews are enough? An experiment with data saturation and variability. Field Methods 2006,18(1):59–82.CrossRef Guest G, Bunce A, Johnson L: How many interviews are enough? An experiment with data saturation and variability. Field Methods 2006,18(1):59–82.CrossRef
15.
go back to reference Kerkhof PC, de Hoop D, de Korte J, Cobelens SA, Kuipers MV: Patient compliance and disease management in the treatment of psoriasis in the Netherlands. Dermatology 2000,200(4):292–298.CrossRef Kerkhof PC, de Hoop D, de Korte J, Cobelens SA, Kuipers MV: Patient compliance and disease management in the treatment of psoriasis in the Netherlands. Dermatology 2000,200(4):292–298.CrossRef
16.
go back to reference Kerkhof PC, de Hoop D, de Korte J, Kuipers MV: Scalp psoriasis, clinical presentations and therapeutic management. Dermatology 1998,197(4):326–334.CrossRef Kerkhof PC, de Hoop D, de Korte J, Kuipers MV: Scalp psoriasis, clinical presentations and therapeutic management. Dermatology 1998,197(4):326–334.CrossRef
17.
go back to reference Dawn A, Yosipovitch G: Treating itch in psoriasis. Dermatol Nurs 2006,18(3):227–233. Dawn A, Yosipovitch G: Treating itch in psoriasis. Dermatol Nurs 2006,18(3):227–233.
18.
go back to reference Verhoeven L, Kraaimaat F, Duller P, Kerkhof P, Evers A: Cognitive, behavioral, and physiological reactivity to chronic itching: analogies to chronic pain. Int J Behav Med 2006,13(3):237–243.CrossRef Verhoeven L, Kraaimaat F, Duller P, Kerkhof P, Evers A: Cognitive, behavioral, and physiological reactivity to chronic itching: analogies to chronic pain. Int J Behav Med 2006,13(3):237–243.CrossRef
19.
go back to reference Amatya B, Nordlind K: Focus groups in Swedish psoriatic patients with pruritus. J Dermatol 2008,35(1):1–5. Amatya B, Nordlind K: Focus groups in Swedish psoriatic patients with pruritus. J Dermatol 2008,35(1):1–5.
20.
go back to reference Zachariae R, Zachariae CO, Lei U, Pedersen AF: Affective and sensory dimensions of pruritus severity: associations with psychological symptoms and quality of life in psoriasis patients. Acta Derm Venereol 2008,88(2):121–127.CrossRef Zachariae R, Zachariae CO, Lei U, Pedersen AF: Affective and sensory dimensions of pruritus severity: associations with psychological symptoms and quality of life in psoriasis patients. Acta Derm Venereol 2008,88(2):121–127.CrossRef
21.
go back to reference Hrehorów E, Reich A, Szepietowski J: Quality of life of patients with psoriasis: relationship with pruritus, stress and symptoms of depression. Dermatologia Kliniczna 2007,9(1):19–23. Hrehorów E, Reich A, Szepietowski J: Quality of life of patients with psoriasis: relationship with pruritus, stress and symptoms of depression. Dermatologia Kliniczna 2007,9(1):19–23.
22.
go back to reference Amatya B, Wennersten G, Nordlind K: Patients' perspective of pruritus in chronic plaque psoriasis: a questionnaire-based study. J Eur Acad Dermatol Venereol 2008,22(7):822–826.CrossRef Amatya B, Wennersten G, Nordlind K: Patients' perspective of pruritus in chronic plaque psoriasis: a questionnaire-based study. J Eur Acad Dermatol Venereol 2008,22(7):822–826.CrossRef
23.
go back to reference Revicki DA, Erickson PA, Sloan JA, Dueck A, Guess H, Santanello NC: Interpreting and reporting results based on patient-reported outcomes. Value Health 2007,10(Suppl 2):S116–124.CrossRef Revicki DA, Erickson PA, Sloan JA, Dueck A, Guess H, Santanello NC: Interpreting and reporting results based on patient-reported outcomes. Value Health 2007,10(Suppl 2):S116–124.CrossRef
24.
go back to reference Burke LB, Kennedy DL, Miskala PH, Papadopoulos EJ, Trentacosti AM: The use of patient-reported outcome measures in the evaluation of medical products for regulatory approval. Clin Pharmacol Ther 2008,84(2):281–283.CrossRef Burke LB, Kennedy DL, Miskala PH, Papadopoulos EJ, Trentacosti AM: The use of patient-reported outcome measures in the evaluation of medical products for regulatory approval. Clin Pharmacol Ther 2008,84(2):281–283.CrossRef
25.
go back to reference Yosipovitch G, Goon A, Wee J, Chan YH, Goh CL: The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol 2000,143(5):969–973.CrossRef Yosipovitch G, Goon A, Wee J, Chan YH, Goh CL: The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol 2000,143(5):969–973.CrossRef
Metadata
Title
The impact of itch symptoms in psoriasis: results from physician interviews and patient focus groups
Authors
Denise Globe
Martha S Bayliss
David J Harrison
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2009
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-7-62

Other articles of this Issue 1/2009

Health and Quality of Life Outcomes 1/2009 Go to the issue